BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37080494)

  • 1. Direct changes of neurometabolic concentrations in the pregenual anterior cingulate cortex among obsessive-compulsive patients after repetitive transcranial magnetic stimulation treatment.
    Luo G; Wang S; Yao S; Quan D; Guo G; Gao J; Zheng H
    J Affect Disord; 2023 Jul; 333():79-85. PubMed ID: 37080494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Effectiveness of Repetitive Transcranial Magnetic Stimulation in the Treatment of Obsessive- Compulsive Disorder.
    Hashempour S; Ansari S; Arbabi M; Etesam F; Sharafi SE; Khaje Vand M; Noorbala AA
    Clin EEG Neurosci; 2022 Nov; 53(6):491-498. PubMed ID: 35275000
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.
    O'Neill J; Gorbis E; Feusner JD; Yip JC; Chang S; Maidment KM; Levitt JG; Salamon N; Ringman JM; Saxena S
    J Psychiatr Res; 2013 Apr; 47(4):494-504. PubMed ID: 23290560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamatergic neurotransmission is affected by low-frequency repetitive transcranial magnetic stimulation over the supplemental motor cortex of patients with obsessive-compulsive disorder.
    Wang J; Hua G; Wang S; Guo G; Quan D; Yao S; Zheng H
    J Affect Disord; 2023 Mar; 325():762-769. PubMed ID: 36681305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of adjunctive low-frequency repetitive transcranial magnetic stimulation therapy over the left dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder refractory to medical treatment:A double-blind, randomized clinical trial.
    Jahanbakhsh G; Alireza Haji Seyed Javadi S; Majidi M; Khademi M; Karimi R
    Asian J Psychiatr; 2023 Feb; 80():103384. PubMed ID: 36565659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorders: Double blind randomized clinical trial.
    Elbeh KAM; Elserogy YMB; Khalifa HE; Ahmed MA; Hafez MH; Khedr EM
    Psychiatry Res; 2016 Apr; 238():264-269. PubMed ID: 27086243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study.
    Rostami R; Kazemi R; Jabbari A; Madani AS; Rostami H; Taherpour MA; Molavi P; Jaafari N; Kuo MF; Vicario CM; Nitsche MA; Salehinejad MA
    BMC Psychiatry; 2020 Jul; 20(1):372. PubMed ID: 32677923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
    Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
    Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive high-frequency right prefrontal repetitive transcranial magnetic stimulation (rTMS) was not effective in obsessive-compulsive disorder but improved secondary depression.
    Sarkhel S; Sinha VK; Praharaj SK
    J Anxiety Disord; 2010 Jun; 24(5):535-9. PubMed ID: 20392594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD).
    Rehn S; Eslick GD; Brakoulias V
    Psychiatr Q; 2018 Sep; 89(3):645-665. PubMed ID: 29423665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal changes in neurometabolite concentrations in the dorsal anterior cingulate cortex after concentrated exposure therapy for obsessive-compulsive disorder.
    de Joode NT; Thorsen AL; Vester EL; Vriend C; Pouwels PJW; Hagen K; Ousdal OT; Hansen B; Kvale G; van den Heuvel OA
    J Affect Disord; 2022 Feb; 299():344-352. PubMed ID: 34920037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind randomized clinical trial of the effectiveness of low frequency rTMS over right DLPFC or OFC for treatment of obsessive-compulsive disorder.
    Khedr EM; Elbeh K; Saber M; Abdelrady Z; Abdelwarith A
    J Psychiatr Res; 2022 Dec; 156():122-131. PubMed ID: 36244200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in error-monitoring and symptoms following low-frequency rTMS of dorsal anterior cingulate cortex in obsessive compulsive disorder; a randomized, sham-controlled study.
    Meek BP; Fotros A; Abo Aoun M; Modirrousta M
    Brain Cogn; 2021 Nov; 154():105809. PubMed ID: 34619574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.
    Li Y; Zhang CC; Kathrin Weidacker ; Zhang Y; He N; Jin H; Chen W; Voon V; Edden RAE; Yan F
    BMC Psychiatry; 2019 May; 19(1):164. PubMed ID: 31146727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamatergic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using magnetic resonance spectroscopy: A controlled study.
    Kosová E; Pajuelo D; Greguš D; Brunovský M; Stopková P; Fajnerová I; Horáček J
    Psychiatry Res Neuroimaging; 2023 Oct; 335():111721. PubMed ID: 37832259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Priming Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Obsessive-Compulsive Disorder: In Search of a New Paradigm!
    Vidya KL; Rao PG; Goyal N
    J ECT; 2022 Mar; 38(1):e1-e8. PubMed ID: 34519685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive transcranial magnetic stimulation (rTMS) for obsessive-compulsive disorder (OCD): an exploratory meta-analysis of randomized and sham-controlled trials.
    Berlim MT; Neufeld NH; Van den Eynde F
    J Psychiatr Res; 2013 Aug; 47(8):999-1006. PubMed ID: 23615189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial.
    Pallanti S; Marras A; Salerno L; Makris N; Hollander E
    J Psychopharmacol; 2016 Jun; 30(6):568-78. PubMed ID: 26843373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive-compulsive disorder: A combined fMRI and
    Chen Y; Meng Z; Zhang Z; Zhu Y; Gao R; Cao X; Tan L; Wang Z; Zhang H; Li Y; Fan Q
    Aust N Z J Psychiatry; 2019 Mar; 53(3):207-218. PubMed ID: 30354192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in metabolite concentrations in tourette's disorder and obsessive-compulsive disorder-A proton magnetic resonance spectroscopy study.
    Fan S; Cath DC; van den Heuvel OA; van der Werf YD; Schöls C; Veltman DJ; Pouwels PJW
    Psychoneuroendocrinology; 2017 Mar; 77():211-217. PubMed ID: 28104554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.